The impact of pre- and post-bypass activated clotting time on postoperative recovery in cardiopulmonary bypass patients at Peshawar Institute of Cardiology, Peshawar Pakistan patients at Peshawar Institute of Cardiology, Peshawar Pakistan
The impact of pre- and post-cardiopulmonary bypass activated clotting time on postoperative recovery
DOI:
https://doi.org/10.52442/jrmi.v12i3.1103Keywords:
Activated Clotting Time, Blood Transfusion, Cardiopulmonary Bypass, Mechanical Ventilation, Postoperative RecoveryAbstract
Introduction: Cardiopulmonary bypass (CPB) is essential in cardiac surgery, but it can lead to complications such as bleeding and prolonged recovery. Activated clotting time (ACT) is crucial for anticoagulation management during CPB. Elevated post-bypass ACT values have been associated with increased postoperative complications, including bleeding, transfusion needs, and prolonged recovery.
Objective: To determine the impact of pre- and post-bypass ACT on postoperative recovery, specifically focusing on ICU stay, mechanical ventilation, transfusions, and bleeding events.
Methodology: This retrospective cohort study was conducted at the Peshawar Institute of Cardiology, Peshawar Pakistan from June 2023 to July 2024, including 250 patients aged 18 years and older undergoing elective cardiac surgery with CPB. Data were collected from patient records, analyzing pre- and post-bypass ACT, CPB duration, and postoperative recovery parameters. Statistical analysis was conducted using SPSS version 25 with p< 0.05 considered statistically significant.
Results: A total of 250 patients were included, with a median age of 56 years. Among CPB patients, 77(30.8%) had a post-bypass ACT≥140 seconds. A significant association was observed between post-bypass ACT≥140 seconds and several adverse postoperative outcomes like, longer mechanical ventilation (p<0.0001), prolonged ICU stays (p<0.0001), increased transfusion rates (p=0.039) and major bleeding events (p<0.0001). The logistic regression model showed post-bypass ACT as a significant predictor for prolonged ICU (OR=1.099, p<0.001) and ventilation stays (OR=1.018, p=0.003).
Conclusion: Elevated post-bypass ACT was associated with prolonged ICU and mechanical ventilation stays, increased transfusion requirements, and major bleeding events. Given the retrospective single-center design, these findings should be considered hypothesis-generating and require prospective multicentre validation.
References
Cribben N, Gonoud D, Kevin LG. Cardiopulmonary bypass. Anaesth Intensive Care Med. 2024;25(3):174-9. DOI: 10.1016/j.mpaic.2023.11.018
Sofa I, Rahman LO. Continuous intra-arterial blood gas monitoring for maintaining tissue perfusion during cardiopulmonary bypass (CPB) in cardiac surgery: A literature review. HJK.2024; 17(9);784-94. DOI: 10.33024/hjk.v17i9.13025
Barbu M, Hjärpe A, Martinsson A, Dellgren G, Ricksten SE, Lannemyr L, et al. Cardiopulmonary bypass management and acute kidney injury in cardiac surgery patients. Acta Anaesthesiol Scand. 2024;68(3):328-36. DOI: 10.1111/aas.14357
Yang X, Zhu L, Pan H, Yang Y. Cardiopulmonary bypass associated acute kidney injury: Better understanding and better prevention. Ren Fail. 2024;46(1):2331062. DOI: 10.1080/0886022X.2024.2331062
Pereira RM, Magueijo D, Guerra NC, Correia CJ, Rodrigues A, Nobre Â, et al. Activated clotting time value as an independent predictor of postoperative bleeding and transfusion. Interdiscip Cardiovasc Thorac Surg. 2024;38(5): ivae092. DOI: 10.1093/icvts/ivae092
Naseer MM, Farooq W, Suleman S, Rasheed M, Ali HS, Khan HA, et al. The effect of temperature and hemodilution on activated clotting time during coronary artery bypass grafting. Biomed Lett. 2022;8(1):92-7. DOI: 10.47262/BL/8.1.20210811
Hanedan MO, Yürük MA, Arslan AK, Kılıç A, Sayar U, Mataracı İ. Heparin-coated vs. non-coated cardiopulmonary bypass circuits: comparing immediate results with different target activated clotting time. Braz J Cardiovasc Surg. 2020;35(6):913-7. DOI: 10.21470/1678-9741-2019-0387
Preuss JF, Matzelle SA, Weightman WM, Gibbs NM. The influence of FIBTEM and EXTEM clotting times on the diagnostic accuracy of ROTEM® sigma identification of hypofibrinogenaemia during cardiac surgery. Anaesthesia. 2022;77(7):829-30. DOI: 10.1111/anae.15735.
Alam W, Hussain SA, Ali M, Akram MA, Farooq MU, Masroor R, et al. Comparison of Two Techniques of Measuring Activated Clotting Time During Cardiac Surgery. Pak Armed Forces Med J. 2022;72(SUPPL-3):47-50. DOI: 10.51253/pafmj.v72iSUPPL-3.9550
Roosendaal LC, Hoebink M, Wiersema AM, Blankensteijn JD, Jongkind V. Activated clotting time-guided heparinization during open AAA surgery: a pilot study. Pilot Feasibility Stud. 2024;10(1):73. DOI: 10.1186/s40814-024-01500-9
Vranken NP, Theelen AJ, Orbons T, Barenbrug PJ, Weerwind PW. Point-of-care measurement of kaolin activated clotting time during cardiopulmonary bypass: A single sample comparison between ACT plus and i-STAT. J Extra Corpor Technol. 2021 Mar 1;53(1):57-61. DOI: 10.1051/ject/202153057
Shore-Lesserson L, Manspeizer HE, Bolastig M, Harrington D, Vela-Cantos F, DePerio M. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time. Anesth Anal. 2000;90(4):813-8. DOI: 10.1213/00000539-200004000-00008
Matsushita S, Kishida A, Wakamatsu Y, Mukaida H, Yokokawa H, Yamamoto T, et al. Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass. Gen Thorac Cardiovasc Surg. 2021; 69:38-43. DOI: 10.1007/s11748-020-01435-
Niinikoski J, Laato M, Laaksonen V, Jalonen J, Inberg MV. Use of activated clotting time to monitor anticoagulation during cardiac surgery. Scand Cardiovasc J. 1984;18(1):57-61. DOI: 10.3109/14017438409099385
Lo B, Fijnheer R, Castigliego D, Borst C, Kalkman CJ, Nierich AP. Activation of hemostasis after coronary artery bypass grafting with or without cardiopulmonary bypass. Anesth Analg. 2004 Sep 1;99(3):634-40. DOI: 10.1213/01.ANE.0000130257.64006.5C
Shirota K, Watanabe T, Takagi Y, Ohara Y, Usui A, Yasuura K. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass. Artif Organs. 2000;24(1):49-56. DOI: 10.1046/j.1525-1594.2000.06340.x
Wachruschew I, Li T, Kuanyshbek A, Tulegenov S, Zhailauova A. The strategy of mechanical ventilation during cardiopulmonary bypass as a predictive factor for pulmonary complications in the intensive care unit. Vestnik Khirurgii Kazakhstana. 2024;28.1(78):12-18. DOI: 10.35805/BSK2024I002
Aladwan H, Alshoubaki W, Alqaisi AI, Abuamereh HA, Alatoum LM, Mohd AF. Impact of duration of cardiopulmonary bypass on recovery after open heart surgery. Int J Adv Med. 2024;11(3):185. DOI: 10.18203/2349-3933.ijam20240922
Khan MG, Khan A, Khan I, Khan S, Shah H, Khan HA. Effect of on-Pump and Off-Pump Coronary Artery Bypass Graft on Length of ICU Stay among Low Ejection Fraction Patients Going through Cardiac Revascularization. J Health Rehab Res. 2024;4(1):1484-9. DOI: 10.61919/jhrr.v4i1.575.
Rustenbach CJ, Reichert S, Berger R, Schano J, Nemeth A, Haeberle H, et al. Unraveling the Predictors for Delirium and ICU Stay Duration in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF) Undergoing Coronary Artery Bypass Grafting—A Multicentric Analysis. Biomedicines. 2024;12(4):749. DOI: 10.3390/biomedicines12040749.
Louis DW, Kennedy K, Lima FV, Pancholy SB, Abbott JD, Gordon P, et al. Association between maximal activated clotting time and major bleeding complications during transradial and transfemoral percutaneous coronary intervention. J Am Coll Cardiol Intv. 2018;11(11):1036-45. DOI: 10.1016/j.jcin.2018.01.257.
Noitz M, Brooks R, Szasz J, Jenner D, Böck C, Krenner N, et al. Acquired factor XIII deficiency is common during ECMO therapy and associated with major bleeding events and transfusion requirements. J Clin Med. 2023;12(12):4115. DOI: 10.3390/jcm12124115.
Kobara YM, Wismer M, Rodrigues FF, de Souza CP. Invasive mechanical ventilation duration prediction using survival analysis. Int J Healthc Manag. 2023:1-1. DOI: 10.1080/20479700.2023.2295111
Sikora A, Zhao B, Kong Y, Murray B, Shen Y. Machine learning based prediction of prolonged duration of mechanical ventilation incorporating medication data. medRxiv. 2023. DOI: 10.1101/2023.09.18.23295724
Alhaid T, Alkathem JA, Humedi AM, Alatawi AA, Alradady RA, Mohamed M, et al. Age and Comorbidity Profiles as Predictors of Mechanical Ventilation Duration in COVID-19 ICU Patients: A Retrospective Study in Saudi Arabia. Cureus. 2024;16(1).e52976. DOI: 10.7759/cureus.52976
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Journal of Rehman Medical Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
